Jazz Pharmaceuticals director proposes $16.2M sale

The notice lists four earlier sales from August 31 through November 2, 2026, including three transactions of 6,000 shares each.

Available on EDGAR 11/06/2026 - 04:41 PM EST Accepted by SEC EDGAR 11/06/2026 - 04:41 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc (JAZZ) director Bruce Cozadd filed a notice for a proposed sale of 68,808 common shares, with an aggregate market value of $16,235,515.95 and an approximate sale date of November 6, 2026. The shares are identified as acquired through a stock option exercise from the issuer, with cash payment; Morgan Stanley Smith Barney LLC is listed as broker. The notice also lists earlier sales of 6,000 shares on November 2, October 1 and September 1, and 1,219 shares on August 31, 2026.

Key Figures

Proposed shares for sale: 68,808 shares Aggregate market value: $16,235,515.95 Common shares outstanding: 64,189,052 shares +4 more

7 metrics

Proposed shares for sale 68,808 shares Approximate sale date: November 6, 2026

Aggregate market value $16,235,515.95 Proposed shares for sale

Common shares outstanding 64,189,052 shares Issuer securities information

Shares sold 6,000 shares November 2, 2026

Shares sold 6,000 shares October 1, 2026

Shares sold 6,000 shares September 1, 2026

Shares sold 1,219 shares August 31, 2026

Key Terms

Rule 144, Stock Option Exercise, Securities To Be Sold

3 terms

Rule 144 regulatory

"sales required by paragraph (e) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many JAZZ shares is Bruce Cozadd proposing to sell?

Bruce Cozadd, a director, reported a proposed sale of 68,808 JAZZ common shares, with an aggregate market value of $16,235,515.95 and an approximate sale date of November 6, 2026.

How were Bruce Cozadd's JAZZ shares to be sold acquired?

The 68,808 common shares are listed as acquired through a stock option exercise from the issuer on November 6, 2026, with cash payment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001193210
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
SEC File Number	001-33500
Address of Issuer	Fifth Floor, Waterloo Exchange Waterloo Road Dublin 4 IRELAND D04 E5W7
Phone	011-353-1-634-7800
Name of Person for Whose Account the Securities are To Be Sold	BRUCE COZADD
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	68808	16235515.95	64189052	11/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/06/2026	Stock Option Exercise	Issuer			68808	11/06/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BRUCE COZADD Fifth Floor, Waterloo Exchange Waterloo Road Dublin 4 L2 D04 E5W7	COMMON	11/02/2026	6000	1295040.00
BRUCE COZADD Fifth Floor, Waterloo Exchange Waterloo Road Dublin 4 L2 D04 E5W7	COMMON	10/01/2026	6000	1381980.00
BRUCE COZADD Fifth Floor, Waterloo Exchange Waterloo Road Dublin 4 L2 D04 E5W7	COMMON	09/01/2026	6000	1500780.00
BRUCE COZADD Fifth Floor, Waterloo Exchange Waterloo Road Dublin 4 L2 D04 E5W7	COMMON	08/31/2026	1219	294281.21

144: Remarks and Signature

Remarks
Date of Notice	11/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Bruce Cozadd
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)